StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries Non-GAAP Gross Profit Margin by Quarter

Non-GAAP Gross Profit Margin (%) (%)

Teva Pharmaceutical Industries Non-GAAP Gross Profit Margin: 58.7% in Q3 2026, up 3.4 pts from a year earlier.

Latest, Q3 2026
58.7%
Period ended Sep 30, 2026
Change on a year earlier
+3.4 pts
55.3% in Q3 2025
History
36 quarters
Since Q4 2017
Sources
36
Documents cited below

Where the Q3 2026 figure comes from

“|| Non-GAAP gross profit margin (2) | 58.7% | 55.3% | 55.8% | 54.3%”

Source: Form 8-K Earnings Release (0001171843-26-007054) ↗

Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Gross Profit Margin (%) (%)Year on yearSource
Q3 2026Sep 30, 202658.7%+3.4 ptsForm 8-K Earnings Release (0001171843-26-007054) ↗
Q2 2026Jun 30, 202655.4%+0.8 ptsForm 8-K Earnings Release (0001171843-26-004974) ↗
Q1 2026Mar 31, 202652.9%+0.1 ptsForm 8-K Earnings Release (0001171843-26-002796) ↗
Q4 2025Dec 31, 202560.3%+5.5 ptsForm 8-K Earnings Release (0001171843-26-000462) ↗
Q3 2025Sep 30, 202555.3%+1.6 ptsForm 8-K Earnings Release (0001171843-25-007000) ↗
Q2 2025Jun 30, 202554.6%+1.7 ptsForm 8-K Earnings Release (0001171843-25-004808) ↗
Q1 2025Mar 31, 202552.8%+1.4 ptsForm 8-K Earnings Release (0001171843-25-002849) ↗
Q4 2024Dec 31, 202454.8%-3.4 ptsForm 8-K Earnings Release (0001171843-25-000493) ↗
Q3 2024Sep 30, 202453.7%+0.2 ptsForm 8-K Earnings Release (0001171843-24-006034) ↗
Q2 2024Jun 30, 202452.9%+0.7 ptsForm 8-K Earnings Release (0001171843-24-004270) ↗
Q1 2024Mar 31, 202451.4%+2.3 ptsForm 8-K Earnings Release (0001193125-24-133759) ↗
Q4 2023Dec 31, 202358.2%+4.0 ptsForm 8-K Earnings Release (0001157523-24-000137) ↗
Q3 2023Sep 30, 202353.5%+0.5 ptsForm 8-K Earnings Release (0001157523-23-001677) ↗
Q2 2023Jun 30, 202352.2%-2.2 ptsForm 8-K Earnings Release (0001157523-23-001212) ↗
Q1 2023Mar 31, 202349.1%-5.1 ptsForm 8-K Earnings Release (0001157523-23-000797) ↗
Q4 2022Dec 31, 202254.2%-1.9 ptsForm 8-K Earnings Release (0001157523-23-000205) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Non-GAAP Gross Profit Margin (%), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-gp-margin

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?